Completed OBSERVATIONAL NCT01617031

Aspirin Twice Daily in Diabetic Patients With Coronary Artery Disease

Biological Efficacy of Twice Daily Aspirin in Type 2 Diabetic Patients With Coronary Artery Disease

Sponsor: Hopital Lariboisière

Updated 6 times since 2017 Last updated: Jun 11, 2012 Started: Sep 30, 2010 Primary completion: Mar 31, 2011 Completion: May 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Diabetes Mellitus, this trial is completed. The trial is conducted by Hopital Lariboisière and has accumulated 6 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: PHASE4 → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Completed PHASE4

First recorded

Sep 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hopital Lariboisière

Data source: Hopital Lariboisière

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Paris, France